1 / 9

North America is to Dominate the Bovine Serum Albumin Market Through 2019-2025

<br>The demand for bovine serum albumin has been growing in accordance with the rise in demand from the pharmaceutical industry. <br>https://www.marketsandmarkets.com/Market-Reports/bovine-serum-albumin-market-20219222.html

mitkekane
Télécharger la présentation

North America is to Dominate the Bovine Serum Albumin Market Through 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents North America is to Dominate the Bovine Serum Albumin Market through 2019- 2025

  2. Introduction The bovine serum albumin market is estimated to account for a value of USD 255 million in 2019 and is projected to grow at a CAGR of 3.0% from 2019, to reach a value of USD 304 million by 2025. The demand for bovine serum albumin has been growing in accordance with the rise in demand from the pharmaceutical industry. The other factors responsible for driving the global market are the changing consumer preferences for a protein-rich diet and high demand from the life sciences industry.  The North American and Asia Pacific countries are witnessing increasing demand for bovine serum albumin for the pharmaceutical and diagnostic industry. The growth of bovine serum albumin market in the North American region spurs from the high demand for red meat & its products, alongside the dynamic changes in the meat processing industry in countries such as the US and Canada. The Asia Pacific region has a growing opportunity for the use of BSA in the pharmaceutical and technical industries, as the pharmaceutical industry is blooming in this region. China is the second-largest pharmaceutical market across the globe. To treat chronic diseases, the research & development sector is witnessing high investments that will significantly drive the demand for innovative drugs. Read more @ https://www.marketsandmarkets.com/PressReleases/bovine-serum-albumin.asp

  3. Key Players Thermo Fisher Scientific (US) Bio-Rad Laboratories, Inc (US) Merck KGAA (Germany) Itoham Yonekyu Holdings Inc (Japan) ProliantBiologicals (US) Kraeber & Co Gmbh (Germany) Rockland ImmunochemicalsInc (US) Rocky mountain biologicals (US) BelHealthinvestment partners, LLC (US) Bio-TechneCorporation (US) Prospec-TanyTechnogene Ltd (Israel) LGC Group (UK) PromegaCorporation (US)

  4. Market Dynamics • Drivers • Inexpensive and Stable Nature of Bovine Serum Albumin as A Protein Standard • Growth of the Livestock Industry and Consequent Demand Generation for Blood-Based Products • Rise in Application in the Food & Pharmaceutical Industries • Restraints • Rise in Demand for Animal-Free Albumin Products • Growth in Appeal to Replace Fetal Bovine Serum and Its Components in Cell Culture Applications

  5. Opportunities • Scope for Use as A Dietary Protein for Fat Reduction • Usage in the Biodegradable and Edible Food Packaging Industry • Challenges • Existence of Alternatives in the Diagnostic and Pharmaceutical Industries

  6. Recent Developments in the Market In November 2017, Proliant Biologicals’ New Zealand facility launched a new reagent grade fatty acid-free BSA, which is derived from animals with origin in New Zealand. In February 2019, Proliant Biologicals launched its product line for Ultra-High Monomer BSA solution that is particularly designed to improve the performance of BSA in critical research. In 2018, Serion GmbH (Germany) expanded its SERION Diagnostics product division to increase its focus into in-vitro diagnostics. In February 2018, Merck KGAA invested USD 44.86 million in a cell culture facility in South Korea to expand its life science segment in the Asia Pacific region; this would help the company to cater to the markets in various geographies. In January 2018, Itoham Yonekyu Holdings Inc. (Japan) acquired Anzco Foods (New Zealand). This helped the company to expand itself in the bovine serum albumin markets of Australia and New Zealand, as it gained the control of Bovogen Biologicals, a subsidiary of Anzco Foods (NewZealand). In September 2018, BelHealth Investment Partners, LLC (US) acquired and invested USD 350 million in Gemini Bioproducts. Due to this investment, a wide range of bio-product manufacturing platform was created. In December 2018, LGC Group (UK) acquired SeraCare Life Sciences, Inc (US) to strengthen its presence in the molecular diagnostics market as well as reinforce its market position in clinical quality control tools.

  7. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

  8. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

More Related